Editorial: Carmustine wafers (Gliadel) plus concomitant temozolomide therapy after resection of malignant astrocytoma: Growing evidence for safety and efficacy

Annals of Surgical Oncology

Volumn 17, Issue 7, 2010, Pages 1729-1731

  McGirt, Matthew J ^a   Brem, Henry ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARMUSTINE; CORTICOSTEROID; TEMOZOLOMIDE; ANTINEOPLASTIC AGENT; BIOMATERIAL; DACARBAZINE; DECANEDIOIC ACID 4,4' (1,3 PROPANEDIYLBIS(OXY))BIS(BENZOIC ACID) COPOLYMER; DECANEDIOIC ACID-4,4'-(1,3-PROPANEDIYLBIS(OXY))BIS(BENZOIC ACID) COPOLYMER; DECANOIC ACID DERIVATIVE; DRUG CARRIER; DRUG DERIVATIVE; POLYESTER;

ABSCESS; ASTROCYTOMA; BIODEGRADABLE IMPLANT; BONE MARROW SUPPRESSION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HUMAN; INFECTION; INTRACRANIAL HYPERTENSION; KARNOFSKY PERFORMANCE STATUS; LIQUORRHEA; MORBIDITY; SEIZURE; WOUND HEALING; WOUND HEALING IMPAIRMENT; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASTROCYTOMA; BIOCOMPATIBLE MATERIALS; CARMUSTINE; DACARBAZINE; DECANOIC ACIDS; DRUG CARRIERS; HUMANS; POLYESTERS; TREATMENT OUTCOME;

EID: 77954900967     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1092-2     Document Type: Editorial

References (13)

1. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987-96.
2. Brem H, Piantadosi S, Burger PC, et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. Lancet. 1995;345:1008-12.
3. Valtonen S, Timonen U, Toivanen P, et al. Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. Neurosurgery. 1997;41:44-8.
4. Westphal M, Hilt DC, Bortey E, et al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neurooncology. 2003;5:79-88.
5. Brem H, Ewend MG, Piantadosi S, et al. The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial. J Neurooncol. 1995;26:111-23.
6. Westphal M, Ram Z, Riddle V, Hilt D, Bortey E. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial. Acta Neurochir (Wien). 2006;148:269-75.
7. Gallia GL, Brem S, Brem H. Local treatment of malignant brain tumors using implantable chemotherapeutic polymers. J Natl Compr Canc Netw. 2005;3:721-8. (Pubitemid 44265417)
8. La Rocca RV, Villanueva WG, Vitaz TW, et al. A phase II study of radiation with concomitant and then sequential temozolomide (TMZ) in patients with newly diagnosed supratentorial high-grade malignant glioma who have undergone surgery with carmustine (BCNU) wafer insertion. Neurooncology. 2006;8:391-500.
9. McGirt MJ, Than KD, Weingart JD, et al. Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. J Neurosurg. 2009;110:583-8.
10. Rich JN, et al. Overall survival of primary glioblastoma (GBM) patients receiving carmustine (BCNU) wafers followed by radiation (RT) and concurrent temozolomide (TMZ) plus rotational multi-agent chemotherapy. J Clin Oncol. 2007;25:2070.
11. Attenello FJ, Mukherjee D, Datoo G, et al. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience. Ann Surg Oncol. 2008;15:2887-93.
12. Menei P, Capelle L, Guyotat J, et al. Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of malignant glioma: a randomized phase II trial. Neurosurgery. 2005;56:242-8.
13. Quinn JA, Jiang SX, Carter J, et al. Phase II trial of Gliadel plus O6-benzylguanine in adults with recurrent glioblastoma multi-forme. Clin Cancer Res. 2009;15:1064-8.